The systemic inflammatory response syndrome: definitions and aetiology.
暂无分享,去创建一个
[1] W. Knaus,et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.
[2] S. Lemeshow,et al. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. , 1993, JAMA.
[3] P. Nyström,et al. Outcome of intra-abdominal infection in pigs depends more on host responses than on microbiology. , 1993, The European journal of surgery = Acta chirurgica.
[4] R. Bone,et al. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.
[5] C. Dinarello,et al. Cytokine Measurements in Septic Shock , 1993, Annals of Internal Medicine.
[6] T. Clemmer,et al. Sepsis syndrome: a valid clinical entity , 1989 .
[7] S. Lowry,et al. An overview of mortality risk prediction in sepsis. , 1995, Critical care medicine.
[8] S. Lemeshow,et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. , 1993, JAMA.
[9] R. Sauerwein,et al. Cytokine Patterns in Patients After Major Vascular Surgery, Hemorrhagic Shock, and Severe Blunt Trauma Relation with Subsequent Adult Respiratory Distress Syndrome and Multiple Organ Failure , 1993, Annals of surgery.
[10] W. Knaus,et al. Evaluation of definitions for sepsis. , 1992, Chest.
[11] A. Cerami,et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. , 1988, Surgery.
[12] D. Pittet,et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.
[13] R. Goris,et al. Multiple-organ failure. Generalized autodestructive inflammation? , 1985, Archives of surgery.
[14] C J Fisher,et al. The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. , 1993, JAMA.
[15] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[16] A. Whitehead,et al. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.
[17] J. Burke,et al. The value and duration of defence reactions of the skin to the primary lodgement of bacteria. , 1957, British journal of experimental pathology.
[18] F. Cerra,et al. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. , 1994, JAMA.
[19] W. Knaus,et al. A comparison of risks and outcomes for patients with organ system failure: 1982-1990. , 1996, Critical care medicine.
[20] C. Sprung,et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.
[21] Roger C. Bone. Definitions for Sepsis and Organ Failure , 1993 .
[22] J. L. Gall,et al. APACHE II--a severity of disease classification system. , 1986, Critical care medicine.
[23] J. Marshall,et al. Microbial infection and the septic response in critical surgical illness. Sepsis, not infection, determines outcome. , 1990, Archives of surgery.
[24] R. Berg,et al. Macrophage Elimination Increases Bacterial Translocation and Gut‐Origin Septicemia but Attenuates Symptoms and Mortality Rate in a Model of Systemic Inflammation , 1993, Annals of surgery.
[25] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.
[26] J. Gauldie,et al. The acute phase response. , 1994, Immunology today.
[27] R. Bone,et al. Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome , 1993, Annals of Internal Medicine.
[28] W. Knaus,et al. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group. , 1996, Critical care medicine.